ASS1 and colorectal carcinoma: Intriguingly, our TMA analysis indicates that in a fraction of CRC patients ASS1 is poorly expressed or undetectable, an occurrence mirrored by RKO and HT29 cell lines, which both demonstrated significant sensitivity to arginine deprivation via ADI-PEG20 treatment in vitro and in vivo.